Free

Addressing the Opioid Crisis: Lessons Learned from the United States

Event Information

Share this event

Date and Time

Location

Location

University Club Of Toronto

380 University Avenue

Main Dining Room

Toronto, ON M5G 1R6

Canada

View Map

Event description

Description

The Canadian Centre on Substance Use and Addiction, with support from the United States Embassy in Ottawa, is holding a cross-Canada speaker series to share knowledge related to the opioid crisis.

The fourth event in the series, entitled Addressing the Opioid Crisis: Lessons Learned from the United States, will be held on Thursday, May 3, 2018 from 9:30 a.m. to 11:30 a.m.

Experts from the US will share learnings and innovative solutions related to the opioid crisis, alongside a local expert sharing the Canadian perspective. The event will include time for discussion among the panel and with the audience about how the work happening in the US relates to, and can inform, the efforts being implemented in Canada.

The panelists are:

Jane C Ballantyne MD FRCA
Dr. Ballantyne received her medical degree from the Royal Free Hospital School of Medicine in London, England. She trained in Anaesthesia at the John Radcliffe Hospital, Oxford, England, before moving to the Massachusetts General Hospital (MGH), Harvard University, Boston in 1990. She began her research career working with statisticians at Harvard School of Public Health and Tufts Center for Evidence-based Medicine, developing an evidence base for Agency for Healthcare Policy and Research (AHCPR, now AHRQ) pain guidelines. She became Chief of the Division of Pain Medicine in MGH in 1999. She moved to the University of Washington in 2011 as UW Medicine Professor of Education and Research. She has editorial roles in several leading journals and textbooks, is a widely published author, and is involved in the development of on-line educational programs. She was a Board member of the International Association for the Study of Pain (IASP) from 2000-2016, was concurrently chair of its Education Endorsement Committee, and is currently chair of its Opioid Position Statement Task Force. In 2014 she was appointed President of Physicians for Responsible Opioid Prescribing (PROP), a group of physicians that promotes rational opioid prescribing through advocacy, research and education.

Miriam Komaromy, MD, FACP, DFASAM
Dr. Komaromy is an Associate Professor of Medicine and Associate Director of the ECHO Institute (echo.unm.edu), which is a program based at the University of New Mexico Health Sciences Center that is aimed at expanding access to treatment for traditionally underserved populations. She is Director for ECHO’s behavioral health intiatives, which engage and support primary care teams in treating addiction and mental health disorders. Through this program she has trained more than 500 US physicians to provide buprenorphine treatment for opioid use disorder, and directs a program that offers Opioid ECHO programs from 5 different hubs across the US. She is board certified in Addiction Medicine and serves on the national Board of Directors of the American Society of Addiction Medicine. She practices addiction medicine in a primary care outpatient setting and has served as medical director for the NM State Addiction Treatment Hospital. She lectures nationally on clinical and health policy issues related to integration of addiction treatment into the primary care setting, and on the use of the ECHO model to train primary care providers to treat common, complex diseases such as mental health and substance use disorders.

Andrew J Smith, MDCM
Dr. Smith is Staff Physician, Pain and Addiction Medicine, Centre for Addiction and Mental Health. He comes from McGill Medicine, University of Washington Neurology and UCLA Medical Genetics, initially focusing on neurodevelopmental medicine. Frustrated by how many of his young patients with learning disabilities would fall into substance use problems despite early successes, he retooled in the emerging field of addiction medicine, and became the first clinical fellow in Canada to do a combined training program in pain and addictions at CAMH and Mount Sinai Hospital (Wasser Clinic). He now leads an inter-professional team at the Pain and Chemical Dependency Clinic at CAMH. Andrew is passionate about improving access to better care for patients with chronic pain and addiction, educating patients, families and clinicians about pain and addiction, and reducing stigma. He is an executive and hub member of ECHO Ontario Chronic Pain — a telementoring resource for primary care clinicians to enhance their skills and confidence in managing more of their own patients who have complex pain and opioid issues.

Share with friends

Date and Time

Location

University Club Of Toronto

380 University Avenue

Main Dining Room

Toronto, ON M5G 1R6

Canada

View Map

Save This Event

Event Saved